ViiV

APRETUDE

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

ViiV

Apretude HCPCS:

J0739

HCPCS Code Descriptor:

Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)

Category:

J Code

Apretude NDCs:

49702-0264-23

Primary Type:

Anti-HIV

Generic/Specialty Status:

Single-Source

Package Type:

Kit

Route of Administration:

Intramuscular

Apretude CPT Codes:

Potential CPT administration codes for Apretude can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Apretude:

APRETUDE is an Anti-HIV drug manufactured by ViiV and administered via the Intramuscular route of administration. The J Code: J0739 is aligned to the drug APRETUDE.

ACCESS PRICING AND MORE BY REGISTERING

J0739 Added Date:

July 1, 2022

J0739 Effective Date:

July 1, 2022

J0739 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Apretude billing and coding information.
Apretude patient assistance information can be found through ViiVConnect at the URL: https://www.viivconnect.com/
APRETUDE prescribing information can be found at the link below:
Information regarding APRETUDE’s side effects can be found at MedlinePlus